IRF8 and metabolic dysfunction-associated steatotic liver disease: Through in vivo and in vitro experiments, we provide evidence that hepatic IRF8 fosters lipid accumulation by positively regulating the transcription of brain and muscle ARNT-like 1 (BMAL1), subsequently increasing PPARγ expression and consequent hepatic steatosis, contributing to the onset of NAFLD.